Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,700 employees worldwide.
A leading global CRO, PRA is transforming clinical trials through our people, innovation and transparency. PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.
INC Research is a leading global CRO providing Phase I to IV clinical development services across six continents. Our global scale and scope, broad therapeutic expertise and commitment to operational excellence using our proven Trusted Process® allow us to develop innovative and flexible strategic alliances.
ICON Plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON has the operational flexibility to provide development services on a stand-alone basis or as part of a full-service solution.
With headquarters in Dublin, Ireland, ICON currently has over 9,400 employees, operating from 82 locations in 40 countries.
inVentiv Health Clinical was launched in January 2013 as the clinical segment of inVentiv Health, a best-in-class team of global healthcare experts offering clinical, commercial and consulting services designed to provide a comprehensive customer experience that delivers greater long term value.
With roots dating back to 1984, inVentiv Health Clinical is an amalgamation of a number of clinical services companies who, when brought together, had the skills and experience to allow inVentiv Health Clinical to become a leading global Clinical Research Organization.
PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 12,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our 20,000 engaged professionals in 60 countries work with an unwavering commitment to patients, safety and ethics. With almost $3 billion in annual revenue, Quintiles is the world’s leading provider of services to the biopharmaceutical industry.
Quintiles helps biopharma companies navigate risk and seize opportunities in an environment where change is constant, which we describe as the New Health.
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries.